In order to demonstrate whether RNF169 plays a role in the patients, we performed immunohistochemical staining of RNF169 in human tissues and found that RNF169 was elevated in PAAD tissues compared with adjacent tissues (Figures 1K, L). This evidence concerns the gene RNF169 and pancreatic adenocarcinoma.